The CDC Group invests $21mn to the Asian Institute of Medical Sciences (AIMS)

By Catherine Sturman
With ambitions to develop businesses across Africa and Asia, boost the number of employment roles and improve local economies, The CDC Group has recentl...

With ambitions to develop businesses across Africa and Asia, boost the number of employment roles and improve local economies, The CDC Group has recently placed significant investment in healthcare provider Asian Institute of Medical Sciences (AIMS)

Established in 1948, the CDC remains the UK’s oldest Development Finance Institution (DFI) and is solely owned by the UK government. Investing up to US$21mn will see the Group work to improve present healthcare services across India, as well as support the development of a five-year hospital expansion into tier 2 and 3 cities in Jharkhand, Bihar and Uttar Pradesh.

The project will see the creation of up to 2,000 new healthcare roles, provide room for up to a thousand new hospital beds at existing facilities and guarantee essential medical training for staff members.

See also

''We're pleased to be able to support a healthcare company that will reach patients that currently have to travel many hours to large cities like Delhi and Calcutta to receive the treatment they need,” commented Srini Nagarajan, managing director and head of South Asia for CDC.

“Our investment in Asian will increase access to high quality care in poorer and under-served cities in Northern and Central India. It will also create many jobs and training opportunities in these cities.”

With three tertiary care hospitals, two secondary hospitals and three health clinics, AIMS has received both NABH and NABL accreditation, with the aim to continually meet the needs of its patients through the use of digital tools and innovative solutions. This is only complemented further through its specialities in cardiology, oncology, orthopaedics and more.

''At Asian, we firmly believe that quality healthcare is a basic need and it needs to be delivered closer to where there is need and not only in big metropolitan centres. We already have our footprint in tier 2 and tier 3 towns. Our association with CDC is going to support us in expanding our services further in states like UP, Bihar and Jharkhand,'' added founder of AIMS N K Pandey.

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19